Category Pharma/Biotech

Compass Pathways Announces U.S. Grant Program Recipients to Support Post-Approval COMP360 Provider Training

Compass Pathways Announces U.S. Grant Program Recipients to Support Post-Approval COMP360 Provider Training Compass Pathways , a biotechnology company focused on developing new treatment options for mental health conditions, has…

Read MoreCompass Pathways Announces U.S. Grant Program Recipients to Support Post-Approval COMP360 Provider Training

Bio-Rad Expands Foresight Pro Chromatography Columns with Nuvia Ion Exchange and Mixed-Mode Resins for Biomanufacturing

Bio-Rad Expands Foresight Pro Chromatography Columns With Nuvia Resins for Biomanufacturing Bio-Rad Laboratories, a global provider of life science research and clinical diagnostics products, has announced the expansion of its…

Read MoreBio-Rad Expands Foresight Pro Chromatography Columns with Nuvia Ion Exchange and Mixed-Mode Resins for Biomanufacturing

Burjeel Holdings Secures BB+ Rating from S&P and Ba2 from Moody’s, Launches USD 1.5 Billion Sukuk Programme

Burjeel Holdings Secures First-Time Credit Ratings and Establishes USD 1.5 Billion Sukuk Programme to Drive Long-Term Growth Burjeel Holdings PLC, one of the Gulf Cooperation Council’s leading super-specialty healthcare providers…

Read MoreBurjeel Holdings Secures BB+ Rating from S&P and Ba2 from Moody’s, Launches USD 1.5 Billion Sukuk Programme